These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39107738)

  • 1. Arginine vasopressin deficiency onset after COVID-19 vaccination with positive anti-rabphilin-3A antibodies: a case report and literature review.
    Takizawa H; Goto H; Uchida T; Aoyama S; Fujisawa H; Iwata N; Suzuki A; Sugimura Y; Watada H
    BMC Endocr Disord; 2024 Aug; 24(1):143. PubMed ID: 39107738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient Central Diabetes Insipidus (Arginine Vasopressin Deficiency) Following SARS-CoV-2 Vaccination: A Case Report and Literature Review.
    Mazzeo P; Ceccato F; Manara R; Mazzon C; Barbot M
    Endocr Metab Immune Disord Drug Targets; 2024; 24(15):1856-1864. PubMed ID: 38243973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of central diabetes insipidus after COVID-19 as a probable diagnosis of lymphocytic infundibulo-neurohypophysitis with positive anti-rabphilin-3A antibodies with review of literature.
    Natsuki Y; Nagata Y; Nagasaki T; Morimoto M; Toi N; Kurajoh M; Morioka T; Shoji T; Imanishi Y; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Emoto M
    Endocr J; 2024 Aug; ():. PubMed ID: 39198191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis.
    Iwama S; Sugimura Y; Kiyota A; Kato T; Enomoto A; Suzuki H; Iwata N; Takeuchi S; Nakashima K; Takagi H; Izumida H; Ochiai H; Fujisawa H; Suga H; Arima H; Shimoyama Y; Takahashi M; Nishioka H; Ishikawa SE; Shimatsu A; Caturegli P; Oiso Y
    J Clin Endocrinol Metab; 2015 Jul; 100(7):E946-54. PubMed ID: 25919460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of anti-rabphilin-3A antibodies for diagnosing central diabetes insipidus in the third trimester of pregnancy.
    Sakurai K; Yamashita R; Niituma S; Iwama S; Sugimura Y; Arihara Z; Takahashi K
    Endocr J; 2017 Jun; 64(6):645-650. PubMed ID: 28420857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of rabphilin-3A in the pathophysiology of experimental lymphocytic neurohypophysitis.
    Yasuda Y; Iwama S; Kiyota A; Izumida H; Nakashima K; Iwata N; Ito Y; Morishita Y; Goto M; Suga H; Banno R; Enomoto A; Takahashi M; Arima H; Sugimura Y
    J Pathol; 2018 Apr; 244(4):469-478. PubMed ID: 29377134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AVP deficiency (central diabetes insipidus) following immunization with anti-COVID-19 BNT162b2 Comirnaty vaccine in adolescents: A case report.
    Partenope C; Pedranzini Q; Petri A; Rabbone I; Prodam F; Bellone S
    Front Endocrinol (Lausanne); 2023; 14():1166953. PubMed ID: 37143723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cullin-associated NEDD8-dissociated protein 1, a novel interactor of rabphilin-3A, deubiquitylates rabphilin-3A and regulates arginine vasopressin secretion in PC12 cells.
    Nakashima K; Takeuchi S; Iwama S; Kiyota A; Yasuda Y; Iwata N; Enomoto A; Arima H; Sugimura Y
    Endocr J; 2018 Mar; 65(3):325-334. PubMed ID: 29367474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case of Lymphocytic Infundibulo-neurohypophysitis Exhibiting Spontaneous Regression.
    Hasebe M; Shibue K; Honjo S; Hamasaki A
    JCEM Case Rep; 2023 Mar; 1(2):luad020. PubMed ID: 37908468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pregnant Woman with Excess Vasopressinase-Induced Diabetes Insipidus Complicated by Central Diabetes Insipidus like Lymphocytic Infundibulo-Neurohypophysitis.
    Yanagisawa S; Oikawa Y; Endo M; Inoue K; Nakajima R; Yasuda S; Sato M; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Isshiki M; Shimada A
    Case Rep Endocrinol; 2024; 2024():8687054. PubMed ID: 38646198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3A antibodies nine years post-onset of central diabetes insipidus.
    Kume Y; Sakuma H; Sekine H; Sumikoshi M; Sugimura Y; Hosoya M
    Clin Pediatr Endocrinol; 2021; 30(1):65-69. PubMed ID: 33446956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two children with lymphocytic hypophysitis presenting with positive anti-rabphilin-3A antibody.
    Murai A; Shinojima N; Ikuta G; Ozono K; Ueda Y; Mabe H; Nakamura K; Iwata N; Fujisawa H; Nagamatsu F; Komatsu N; Uekawa K; Nishikawa S; Nakamura K; Mikami Y; Suzuki A; Sugimura Y; Mukasa A
    Endocr J; 2023 Jul; 70(7):703-709. PubMed ID: 37045780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central diabetes insipidus with anti-rabphilin-3A antibody positivity causing hypovolemic shock after resection of tumorous lesions in the pelvic cavity.
    Ohashi A; Takeda Y; Watada M; Ihara F; Oshita T; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Maeda Y
    CEN Case Rep; 2023 Aug; 12(3):297-303. PubMed ID: 36574196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal study of vasopressin-cell antibodies and of hypothalamic-pituitary region on magnetic resonance imaging in patients with autoimmune and idiopathic complete central diabetes insipidus.
    De Bellis A; Colao A; Bizzarro A; Di Salle F; Coronella C; Solimeno S; Vetrano A; Pivonello R; Pisano G; Lombardi G; Bellastella A
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3825-9. PubMed ID: 12161517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocytic Infundibuloneurohypophysitis Diagnosis Owing to Positive Anti-rabphilin-3A Antibody Test Result in an 8-year-old Boy with Early-onset Central Diabetes İnsipidus.
    Shoji Y; Naruse Y; Iwata N; Fujisawa H; Suzuki A; Sugimura Y; Mori M; Hiramoto R
    J Clin Res Pediatr Endocrinol; 2023 Sep; ():. PubMed ID: 37743662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypopituitarism with secondary adrenocortical insufficiency and arginine vasopressin deficiency due to hypophysitis after COVID-19 vaccination: a case report.
    Watanabe S; Tamura Y; Oba K; Kitayama S; Sato M; Kodera R; Toyoshima K; Chiba Y; Araki A
    BMC Endocr Disord; 2024 May; 24(1):71. PubMed ID: 38769570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of hypophysitis after COVID-19 vaccination with a detection of anti-pituitary antibody, with review of literature.
    Kyo C; Kobayashi T; Iwama S; Kosugi R; Sawabe F; Hayafusa R; Sakai Y; Ogawa T; Kotani M; Inoue T; Arima H; Ariyasu H
    Endocr J; 2024 Aug; 71(8):799-807. PubMed ID: 38710620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies.
    Bellucci M; Bozzano FM; Castellano C; Pesce G; Beronio A; Farshchi AH; Limongelli A; Uccelli A; Benedetti L; De Maria A
    Front Immunol; 2024; 15():1398028. PubMed ID: 39148725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of anti-rabphilin-3A antibodies in children and young adults with idiopathic central diabetes insipidus: a potential clue to elucidating a tumor etiology.
    Fujisawa H; Takeuchi T; Ishii A; Muto J; Kamasaki H; Suzuki A; Sugimura Y
    Hormones (Athens); 2023 Dec; 22(4):747-758. PubMed ID: 37697216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune hepatitis triggered by SARS-CoV-2 vaccination.
    Vuille-Lessard É; Montani M; Bosch J; Semmo N
    J Autoimmun; 2021 Sep; 123():102710. PubMed ID: 34332438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.